Back to Market Feed

Product Information

HORIZANT ER 300 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $17.9293 per EA under NDC 53451010301. Its NADAC has been published 601 times since Feb 18, 2015.

FDA first approved this application on Apr 6, 2011.

HORIZANT ER 300 MG TABLET

gabapentin enacarbil
$17.9293per EA

Strength

300 mg/1

NDC

53451010301

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN ENACARBIL

Approval Type

New Drug (NDA)

FDA Application

NDA022399

FDA Approved

4/6/2011

On Market Since

5/1/2013

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for HORIZANT ER 300 MG TABLET has been published 601 times since Feb 18, 2015, and over the history we have for it it has risen 137.3%. The table below summarizes its recorded NADAC range and movement.

Current price$17.9293 per EA
All-time high$17.9791 (Jun 11, 2025)
All-time low$7.5545 (Feb 18, 2015)
52-week high$17.9535
52-week low$17.9214
Median price$13.6544
Average price$13.7274
Largest weekly change+18.0% (Jan 13, 2016)
Weeks tracked601
Tracking sinceFeb 18, 2015

Price History

1W

+0.0%

1M

+0.0%

3M

+0.0%

6M

-0.1%

1Y

-0.1%

3Y

+19.7%

5Y

+28.2%

All

+137.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the gabapentin enacarbil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TEGRETOL 100 MG/5 ML SUSP
Brand
00078050883•Novartis Pharmaceuticals Corporation
$0.4370
per ML
ZARONTIN 250 MG CAPSULE
Brand
00071023724•Pfizer Inc.
$1.3086
per EA
EPRONTIA 25 MG/ML SOLUTION
Brand
52652900101•Azurity Pharmaceuticals Inc.
$1.5811
per ML
TEGRETOL XR 100 MG TABLET
Brand
00078051005•Novartis Pharmaceuticals Corporation
$1.6273
per EA
CARBATROL ER 200 MG CAPSULE
Brand
54092017212•Takeda Pharmaceuticals America, Inc.
$1.6940
per EA
CARBATROL ER 300 MG CAPSULE
Brand
54092017312•Takeda Pharmaceuticals America, Inc.
$1.6952
per EA
CARBATROL ER 100 MG CAPSULE
Brand
54092017112•Takeda Pharmaceuticals America, Inc.
$1.6996
per EA
KEPPRA 100 MG/ML ORAL SOLN
Brand
50474000148•UCB, Inc.
$1.9186
per ML
TRILEPTAL 300 MG/5 ML SUSP
Brand
00078035752•Novartis Pharmaceuticals Corporation
$1.9303
per ML
DEPAKOTE DR 125 MG SPRINKLE CP
Brand
00074611413•AbbVie Inc.
$1.9659
per EA

Frequently asked questions

What is the NADAC price of HORIZANT ER 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HORIZANT ER 300 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $17.9293 per EA (NDC 53451010301), effective Aug 19, 2026.

How has the price of HORIZANT ER 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for HORIZANT ER 300 MG TABLET has risen 137.3%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for HORIZANT ER 300 MG TABLET?

Since Feb 18, 2015, the NADAC for HORIZANT ER 300 MG TABLET has ranged from a low of $7.5545 (Feb 18, 2015) to a high of $17.9791 (Jun 11, 2025), with a median of $13.6544 per EA.

Are there cheaper alternatives to HORIZANT ER 300 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of HORIZANT ER 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures HORIZANT ER 300 MG TABLET?

HORIZANT ER 300 MG TABLET (NDC 53451010301) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.